Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

about

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

Item

http://www.wikidata.org/entity/Q35890630

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

@ast

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

@en

type

Item

label

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

@ast

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

@en

prefLabel

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

@ast

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

@en

P1476

Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012.

@en

P2093

Roger Baxter

http://www.w3.org/2001/XMLSchema#string

P2860

The Vaccine Safety Datalink: a model for monitoring immunization safety

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study

Surveillance lessons from first-wave pandemic (H1N1) 2009, Northern California, USA.

Safety of quadrivalent human papillomavirus vaccine administered routinely to females.

Treatment with monoclonal antibodies against Clostridium difficile toxins.

Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents

Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization.

Influenza vaccination and mortality: differentiating vaccine effects from bias.

Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra

P304

139-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/VACCINES1020139

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicola P Klein

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276044416

http://www.w3.org/2001/XMLSchema#string

P698

26343963

http://www.w3.org/2001/XMLSchema#string

P932

4515583

http://www.w3.org/2001/XMLSchema#string